CPMG Inc - Q1 2023 holdings

$496 Million is the total value of CPMG Inc's 5 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 25.0% .

 Value Shares↓ Weighting
RETA  REATA PHARMACEUTICALS INCcl a$263,386,239
+139.3%
2,896,9010.0%53.13%
+92.2%
 PROCEPT BIOROBOTICS CORP$151,339,823
-31.6%
5,328,8670.0%30.53%
-45.1%
APEN  APOLLO ENDOSURGERY INC$61,341,342
-0.5%
6,183,6030.0%12.37%
-20.1%
NewINTUITIVE MACHINES INC$14,269,7811,321,276
+100.0%
2.88%
TIL  INSTIL BIO INC$5,430,763
+4.9%
8,218,4670.0%1.10%
-15.8%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
REATA PHARMACEUTICALS INC23Q2 202376.8%
APOLLO ENDOSURGERY INC22Q1 202315.5%
INVESCO QQQ TR15Q4 20211.4%
FIRST TR NASDAQ-100 TECH IND13Q4 20200.1%
KIRKLAND LAKE GOLD LTD12Q3 20206.5%
INSTIL BIO INC11Q3 202340.7%
TIDEWATER INC NEW11Q4 20201.3%
PROCEPT BIOROBOTICS CORP9Q3 202395.6%
INTUITIVE SURGICAL INC9Q4 201970.1%
UNITED RENTALS INC9Q4 201921.0%

View CPMG Inc's complete holdings history.

Latest significant ownerships (13-D/G)
CPMG Inc Q1 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
REATA PHARMACEUTICALS INCSold outSeptember 28, 202300.0%
Apollo Endosurgery, Inc.Sold outApril 05, 202300.0%
PROCEPT BioRobotics CorpDecember 07, 20225,328,86711.9%
Instil Bio, Inc.April 01, 20218,478,7906.6%
GOLDEN STAR RESOURCES LTD.Sold outFebruary 17, 202100.0%
GENITOPE CORPSold outDecember 12, 200800.0%

View CPMG Inc's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
42023-09-28
SC 13D/A2023-09-28
13F-HR2023-08-14
SC 13D/A2023-08-01
13F-HR2023-05-15
SC 13D/A2023-04-05
42023-04-04
13F-HR2023-02-14

View CPMG Inc's complete filings history.

Compare quarters

Export CPMG Inc's holdings